Chengdu Kanghong Pharma Grp Co Ltd (002773 ፦ ) የአክሲዮን ዋጋ እና ዜና

(CNY)	ማርች 2025	ከዓመት ዓመት ለውጥ
ገቢ	1.20 ቢ	9.70%
የሥራ ወጪ	622.89 ሚ	13.69%
የተጣራ ገቢ	400.02 ሚ	7.09%
የተጣራ የትርፍ ክልል	—	—
ገቢ በሼር	—	—
EBITDA	507.93 ሚ	4.67%
ውጤታማ የግብር ተመን	14.30%	—

ቀሪ ሒሳብ ሉሆች

አጠቃላይ ንብረቶች

አጠቃላይ ተጠያቂነቶች

(CNY)	ማርች 2025	ከዓመት ዓመት ለውጥ
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ	6.08 ቢ	20.00%
አጠቃላይ ንብረቶች	9.67 ቢ	9.50%
አጠቃላይ ተጠያቂነቶች	627.52 ሚ	-3.45%
አጠቃላይ እሴት	9.05 ቢ	—
የሼሮቹ ብዛት	919.87 ሚ	—
የገበያ ዋጋ እና የተገለጸ ዋጋ	2.84	—
የእሴቶች ተመላሽ	—	—
የካፒታል ተመላሽ	12.73%	—

የገንዘብ ፍሰት

የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ

(CNY)	ማርች 2025	ከዓመት ዓመት ለውጥ
የተጣራ ገቢ	400.02 ሚ	7.09%
ከክወናዎች የተገኘ ጥሬ ገንዘብ	433.08 ሚ	6.69%
ገንዘብ ከኢንቨስትመንት	-2.69 ቢ	-34.16%
ገንዘብ ከፋይናንስ	-1.21 ሚ	-1,025.44%
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ	-2.26 ቢ	-41.20%
ነፃ የገንዘብ ፍሰት	143.20 ሚ	11.91%

ስለ

Chengdu Kanghong Pharmaceutical Group Co., Ltd. is a publicly traded pharmaceutical company based in the province of Sichuan, China. It was founded in 1996 and researches, develops, manufactures, and distributes medicines for ophthalmic, central nervous, digestive and endocrine systems. The company is listed on the Shenzhen stock exchange with a market capitalization at around $6 billion. As of May 2021, the company had 18 drugs on the market including Lumitin. Additional products include Songling xuemaikang capsules, Keluoxin capsules, Xinluona, Bolexin and Bosiqing, Yitaning, Shugan Jieyu, Danshu, and Yiqing. Kanghong also currently has 13 subsidiaries in China, Israel, and the United States. Wikipedia

የተመሰረተው

3 ኦክቶ 1996

ድህረገፅ

cnkh.com

ሠራተኞች

4,462